ho 1 crispr cas9 ko plasmid Search Results


crispr cas9 system  (Santa Cruz Biotechnology)
94
Santa Cruz Biotechnology crispr cas9 system
Crispr Cas9 System, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ho+1+crispr+cas9+ko+plasmid/Heme+Oxygenase+1+CRISPR%2FCas9+KO+Plasmid/pm41934679-54-4-12
Average 94 stars, based on 1 article reviews
crispr cas9 system - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier
sod2  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology sod2
Bucillamine induces phase II antioxidants and detoxifying enzymes in HEI-OC1 cells treated with cisplatin. ( a ) Cells were pretreated with 2 m M bucillamine for 1 h followed by the addition of 20 μ M cisplatin at 12 h. Phase II antioxidant genes ( HO-1 , SOD1 and <t>SOD2</t> ) from total RNA were amplified using specific primer sets. Expression levels of HO-1, SOD1 and SOD2 were significantly increased by the pretreatment with bucillamine as compared with cisplatin alone at 12 h. ( b ) Cell lysates were electrophoresed through an SDS-polyacrylamide gel and subject to immunoblot analysis for HO-1, SOD1 and SOD2.
Sod2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ho+1+crispr+cas9+ko+plasmid/BBS12+CRISPR%2FCas9+KO+Plasmid/pmc04346486-100-9-18
Average 90 stars, based on 1 article reviews
sod2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
hdr plasmid  (Santa Cruz Biotechnology)
94
Santa Cruz Biotechnology hdr plasmid
Bucillamine induces phase II antioxidants and detoxifying enzymes in HEI-OC1 cells treated with cisplatin. ( a ) Cells were pretreated with 2 m M bucillamine for 1 h followed by the addition of 20 μ M cisplatin at 12 h. Phase II antioxidant genes ( HO-1 , SOD1 and <t>SOD2</t> ) from total RNA were amplified using specific primer sets. Expression levels of HO-1, SOD1 and SOD2 were significantly increased by the pretreatment with bucillamine as compared with cisplatin alone at 12 h. ( b ) Cell lysates were electrophoresed through an SDS-polyacrylamide gel and subject to immunoblot analysis for HO-1, SOD1 and SOD2.
Hdr Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ho+1+crispr+cas9+ko+plasmid/Heme+Oxygenase+1+HDR+Plasmid/pm41934679-54-19-12
Average 94 stars, based on 1 article reviews
hdr plasmid - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier
gapdh santa cruz sc420485  (Santa Cruz Biotechnology)
92
Santa Cruz Biotechnology gapdh santa cruz sc420485
Bucillamine induces phase II antioxidants and detoxifying enzymes in HEI-OC1 cells treated with cisplatin. ( a ) Cells were pretreated with 2 m M bucillamine for 1 h followed by the addition of 20 μ M cisplatin at 12 h. Phase II antioxidant genes ( HO-1 , SOD1 and <t>SOD2</t> ) from total RNA were amplified using specific primer sets. Expression levels of HO-1, SOD1 and SOD2 were significantly increased by the pretreatment with bucillamine as compared with cisplatin alone at 12 h. ( b ) Cell lysates were electrophoresed through an SDS-polyacrylamide gel and subject to immunoblot analysis for HO-1, SOD1 and SOD2.
Gapdh Santa Cruz Sc420485, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ho+1+crispr+cas9+ko+plasmid/GAPDH+CRISPR%2FCas9+KO+Plasmid/ppr0746615-46-60-61
Average 92 stars, based on 1 article reviews
gapdh santa cruz sc420485 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier
ho 1 crispr cas9 ko plasmids  (Santa Cruz Biotechnology)
95
Santa Cruz Biotechnology ho 1 crispr cas9 ko plasmids
Bucillamine induces phase II antioxidants and detoxifying enzymes in HEI-OC1 cells treated with cisplatin. ( a ) Cells were pretreated with 2 m M bucillamine for 1 h followed by the addition of 20 μ M cisplatin at 12 h. Phase II antioxidant genes ( HO-1 , SOD1 and <t>SOD2</t> ) from total RNA were amplified using specific primer sets. Expression levels of HO-1, SOD1 and SOD2 were significantly increased by the pretreatment with bucillamine as compared with cisplatin alone at 12 h. ( b ) Cell lysates were electrophoresed through an SDS-polyacrylamide gel and subject to immunoblot analysis for HO-1, SOD1 and SOD2.
Ho 1 Crispr Cas9 Ko Plasmids, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ho+1+crispr+cas9+ko+plasmid/SP-A1+CRISPR%2FCas9+KO+Plasmid/pm35972707-57-9-36
Average 95 stars, based on 1 article reviews
ho 1 crispr cas9 ko plasmids - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


Bucillamine induces phase II antioxidants and detoxifying enzymes in HEI-OC1 cells treated with cisplatin. ( a ) Cells were pretreated with 2 m M bucillamine for 1 h followed by the addition of 20 μ M cisplatin at 12 h. Phase II antioxidant genes ( HO-1 , SOD1 and SOD2 ) from total RNA were amplified using specific primer sets. Expression levels of HO-1, SOD1 and SOD2 were significantly increased by the pretreatment with bucillamine as compared with cisplatin alone at 12 h. ( b ) Cell lysates were electrophoresed through an SDS-polyacrylamide gel and subject to immunoblot analysis for HO-1, SOD1 and SOD2.

Journal: Experimental & Molecular Medicine

Article Title: Bucillamine prevents cisplatin-induced ototoxicity through induction of glutathione and antioxidant genes

doi: 10.1038/emm.2014.112

Figure Lengend Snippet: Bucillamine induces phase II antioxidants and detoxifying enzymes in HEI-OC1 cells treated with cisplatin. ( a ) Cells were pretreated with 2 m M bucillamine for 1 h followed by the addition of 20 μ M cisplatin at 12 h. Phase II antioxidant genes ( HO-1 , SOD1 and SOD2 ) from total RNA were amplified using specific primer sets. Expression levels of HO-1, SOD1 and SOD2 were significantly increased by the pretreatment with bucillamine as compared with cisplatin alone at 12 h. ( b ) Cell lysates were electrophoresed through an SDS-polyacrylamide gel and subject to immunoblot analysis for HO-1, SOD1 and SOD2.

Article Snippet: Predesigned small interference RNAs (siRNAs) against mouse HO-1 (sc-35555), SOD2 (sc-416560) and control siRNA (sc-37007) were purchased from Santa Cruz Biotechnology.

Techniques: Amplification, Expressing, Western Blot

siRNA knockdown of HO-1 and SOD2 enzymes does not completely block the protective effects of bucillamine. ( a ) After transfection of HEI-OC1 cell with double-stranded siRNA (HO-1, SOD2 or both), cells were pretreated with various concentrations of bucillamine for 1 h followed by the addition of 20 μ M cisplatin for 24 h. Then, cell viability was measured by MTT assays. ( b ) Cell lysates were subject to immunoblot analysis with antibodies against pro-caspase-3 and active form of caspase-3. β-actin was used as a control.

Journal: Experimental & Molecular Medicine

Article Title: Bucillamine prevents cisplatin-induced ototoxicity through induction of glutathione and antioxidant genes

doi: 10.1038/emm.2014.112

Figure Lengend Snippet: siRNA knockdown of HO-1 and SOD2 enzymes does not completely block the protective effects of bucillamine. ( a ) After transfection of HEI-OC1 cell with double-stranded siRNA (HO-1, SOD2 or both), cells were pretreated with various concentrations of bucillamine for 1 h followed by the addition of 20 μ M cisplatin for 24 h. Then, cell viability was measured by MTT assays. ( b ) Cell lysates were subject to immunoblot analysis with antibodies against pro-caspase-3 and active form of caspase-3. β-actin was used as a control.

Article Snippet: Predesigned small interference RNAs (siRNAs) against mouse HO-1 (sc-35555), SOD2 (sc-416560) and control siRNA (sc-37007) were purchased from Santa Cruz Biotechnology.

Techniques: Knockdown, Blocking Assay, Transfection, Western Blot, Control